Bank of New York Mellon Corp
BankPosition in PCRX — Pacira BioSciences, Inc.
CIK 1390777
NEW YORK, NY
Position in PCRX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$6,839,413
-$1,691,046 QoQ
Shares Held
302,629
-8.2% QoQ
Ownership
0.769%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 90.79268675506974.ToString("F0")%
Shared 0.ToString("F0")%
None 9.207313244930262.ToString("F0")%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $1,371,862,681 across 46 Drug Manufacturers - Specialty & Generic names. PCRX ranks #20 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,899,720 | $460,985,889 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
329,148 | $195,178,172 | |
| 3 | VTRS |
Viatris Inc
|
14,128,917 | $190,881,662 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
702,492 | $92,546,288 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,809,888 | $91,170,611 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,794,432 | $54,048,287 | |
| 7 | ALKS |
Alkermes plc.
|
1,036,460 | $36,649,221 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
463,751 | $35,175,507 |
All Filings in PCRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,839,413 | 302,629 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $8,530,459 | 329,616 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $9,448,359 | 366,642 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $9,233,378 | 386,334 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $9,595,798 | 386,149 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $7,468,153 | 396,399 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $5,335,494 | 354,518 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $11,444,054 | 400,002 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $11,625,495 | 397,861 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $14,346,885 | 425,219 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $13,920,769 | 453,741 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $18,857,539 | 470,615 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $19,690,617 | 482,495 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $18,052,218 | 467,553 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $25,731,618 | 483,768 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $27,678,855 | 474,766 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $39,147,959 | 512,945 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $29,903,583 | 496,985 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $26,776,960 | 478,160 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $28,682,704 | 472,688 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $33,875,686 | 483,317 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $30,803,680 | 512,370 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $27,474,915 | 523,631 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $16,471,140 | 491,236 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||